Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Technical Analysis

1,114 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Fate Therapeutics’s (FATE) Moving Averages Convergence Divergence (MACD) indicator is 0.41, suggesting Fate Therapeutics is a Sell.
Fate Therapeutics’s (FATE) 20-Day exponential moving average is 4.24, while Fate Therapeutics’s (FATE) share price is $5.44, making it a Buy.
Fate Therapeutics’s (FATE) 50-Day exponential moving average is 4.11, while Fate Therapeutics’s (FATE) share price is $5.44, making it a Buy.

Fate Therapeutics (FATE) Pivot Points

Jul 27, 2024, 12:59 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.43
4.79
4.99
5.35
5.55
5.91
6.11
Fibonacci
4.79
5.01
5.14
5.35
5.57
5.70
5.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Fate Therapeutics (FATE) Moving Averages

Jul 27, 2024, 12:59 AM
Period
Simple
Exponential
MA5
5.00Buy
5.05Buy
MA10
4.58Buy
4.66Buy
MA20
3.90Buy
4.24Buy
MA50
3.79Buy
4.11Buy
MA100
4.87Buy
4.33Buy
MA200
4.32Buy
3.96Buy
Fate Therapeutics’s (FATE) 10-Day exponential moving average is 4.66, while Fate Therapeutics’s (FATE) share price is $5.44, making it a Buy.
Fate Therapeutics’s (FATE) 100-Day exponential moving average is 4.33, while Fate Therapeutics’s (FATE) share price is $5.44, making it a Buy.
Fate Therapeutics’s (FATE) stock price is $5.44 and Fate Therapeutics’s (FATE) 50-day simple moving average is 3.79, creating a Buy signal.
Fate Therapeutics’s (FATE) stock price is $5.44 and Fate Therapeutics’s (FATE) 100-day simple moving average is 4.87, creating a Buy signal.
Fate Therapeutics’s (FATE) stock price is $5.44 and Fate Therapeutics’s (FATE) 200-day simple moving average is 4.32, creating a Buy signal.

Fate Therapeutics (FATE) Technical Indicators

Jul 27, 2024, 12:59 AM
Name
Value
Implied Action
RSI (14)
71.73
Sell
STOCH (9,6)
86.54
Sell
STOCHRSI (14)
88.61
Sell
MACD (12,26)
0.41
Sell
ADX (14)
33.96
Neutral
Williams %R
-11.87
Sell
CCI (14)
145.55
Sell
ATR (14)
0.41
-
Ultimate Oscillator
56.79
Neutral
ROC
70.35
Buy
Fate Therapeutics’s (FATE) Relative Strength Index (RSI) is 71.73, creating a Sell signal.
Fate Therapeutics’s (FATE) Trend Strength Indicator (ADX) is 33.96, creating a Neutral signal.
Fate Therapeutics’s (FATE) Commodity Channel Index (CCI) is 145.55, creating a Sell signal.
Fate Therapeutics’s (FATE) Price Rate of Change (ROC) is 70.35, creating a Buy signal.

FAQ

Is FATE a Buy, Hold, or Sell?
Based on FATE’s technical indicators, FATE is a Buy.
    What is FATE’s RSI (14)?
    FATE’s RSI (14) is 71.73, which suggests FATE is a Sell.
      What is FATE’s MACD?
      FATE’s MACD is 0.41, which suggests FATE is a Sell.
        What is FATE’s 5-day moving average?
        FATE’s 5-day moving average is 5.00, which suggests FATE is a Buy.
          What is FATE’s 20-day moving average?
          FATE 20-day moving average is 3.90, which suggests FATE is a Buy.
            What is FATE’s 50-day moving average?
            FATE’s 50-day moving average is 3.79, which suggests FATE is a Buy.
              What is FATE’s 200-day moving average?
              FATE’s 200-day moving average is 4.32, which suggests FATE is a Buy.
                What is FATE’s Williams % R (14)?
                FATE’s Williams % R (14) is -11.87, which suggests FATE is a Sell.
                  What is FATE’s CCI (14)?
                  FATE’s CCI (14) is 145.55, which suggests FATE is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis